From: Virological and clinical characteristics of hepatitis delta virus in South Asia
Total n = 480 | HBeAg positive n = 164 | HBeAg negative n = 316 | p value | |
---|---|---|---|---|
Age, years | 33 ± 12.53 | 30 ± 13.36 | 34.28 ± 11.87 | < 0.001 |
Gender | ||||
Male | 398(82.9) | 138(84.1) | 260(82.3) | 0.60 |
Female | 82(17.1) | 26(15.9) | 56(17.7) | |
ALT | 66.07 ± 72.83 | 73.95 ± 79.04 | 61.98 ± 69.16 | 0.10 |
Median ALT | 38(9-500) | 42(9-500) | 35(10-496) | |
Normal | 247 (51.5) | 73(44.5) | 174(55.1) | 0.02 |
Raised | 233 (48.5) | 91(55.5) | 142(44.9) | |
HBV DNA level | ||||
≥ 10e5 | 103 (21.5) | 83 (50.9) | 20 (15.3) | < 0.001 |
< 10e5 | 377 (78.5) | 80 (49.1) | 111 (84.7) | |
Anti HDV | ||||
Reactive | 169 (35.2) | 41 (25) | 128 (40.5) | 0.001 |
Non reactive | 311 (64.8) | 123 (75) | 188 (59.5) | |
HDV RNA qualitative | ||||
Positive | 49 (10.2) | 7 (5.7) | 42 (13.8) | < 0.001 |
Negative | 67 (14) | 7 (5.7) | 60 (19.7) | |
HBV stage | ||||
Carrier of HBV | 143 (29.8) | 0 | 143 (45) | < 0.001 |
Chronic active HBV | 185 (38.5) | 75 (45.7) | 110 (34.8) | |
Compensate cirrhosis with HBV | 72(15) | 22 (13.4) | 50 (15.8) | 0.48 |
Immunotolerant phase | 80 (16.7) | 60 (36.6) | 20 (6.3) | NS |